| Literature DB >> 35474566 |
Marine Thomasson1,2,3, Damien Benis1,2, Philippe Voruz1,2,3, Arnaud Saj4, Marc Vérin5,6, Frédéric Assal3,7, Didier Grandjean2, Julie Péron8,9.
Abstract
There is growing evidence that both the basal ganglia and the cerebellum play functional roles in emotion processing, either directly or indirectly, through their connections with cortical and subcortical structures. However, the lateralization of this complex processing in emotion recognition remains unclear. To address this issue, we investigated emotional prosody recognition in individuals with Parkinson's disease (model of basal ganglia dysfunction) or cerebellar stroke patients, as well as in matched healthy controls (n = 24 in each group). We analysed performances according to the lateralization of the predominant brain degeneration/lesion. Results showed that a right (basal ganglia and cerebellar) hemispheric dysfunction was likely to induce greater deficits than a left one. Moreover, deficits following left hemispheric dysfunction were only observed in cerebellar stroke patients, and these deficits resembled those observed after degeneration of the right basal ganglia. Additional analyses taking disease duration / time since stroke into consideration revealed a worsening of performances in patients with predominantly right-sided lesions over time. These results point to the differential, but complementary, involvement of the cerebellum and basal ganglia in emotional prosody decoding, with a probable hemispheric specialization according to the level of cognitive integration.Entities:
Keywords: Basal ganglia; Cerebellum; Parkinson’s disease; Vocal emotion
Mesh:
Year: 2022 PMID: 35474566 PMCID: PMC9458588 DOI: 10.3758/s13415-022-01000-4
Source DB: PubMed Journal: Cogn Affect Behav Neurosci ISSN: 1530-7026 Impact factor: 3.526
Statistical results of comparisons between the two subgroups of patients with PD (LPD and RPD) on motor, neuropsychological and psychiatric data
| LPD (mean ± | RPD (mean ± | Stat. value | ||
|---|---|---|---|---|
| L-DOPA equivalent dose (mg/day) | 1302.92 ± 598.45 | 1295.58 ± 582.22 | 0.20 | 0.96 |
| Hoehn and Yahr score on dopa | 1.04 ± 0.86 | 9.46 ± 28.84 | 0.58 | 0.86 |
| Hoehn and Yahr score off dopa | 2.12 ± 0.74 | 10.92 ± 28.38 | 1.64 | 0.44 |
| Schwab and England score on dopa | 90.00 ± 8.53 | 83.50 ± 27.19 | 0.09 | 0.97 |
| Schwab and England score off dopa | 72.50 ± 11.38 | 58.62 ± 33.52 | -0.87 | 0.86 |
| UPDRS-III motor score on dopa | 8.37 ± 6.66 | 6.96 ± 4.72 | -0.32 | 0.89 |
| UPDRS-III motor score off dopa | 30.87 ± 9.37 | 34.04 ± 16.09 | 0.32 | 0.89 |
| Asymmetry index | -2.67 ± 2.31 | 0.50 ± 1.19 | 3.23 | 0.07 |
| MDRS (total score) | 140.67 ± 1.72 | 139.83 ± 3.21 | -0.58 | 0.86 |
| Categorical verbal fluency | 27.25 ± 13.79 | 30.33 ± 10.67 | 0.84 | 0.85 |
| Action (Verb) Fluency | 14.50 ± 6.87 | 14.00 ± 6.69 | -0.06 | 0.97 |
| Phonemic verbal fluency | 20.83 ± 7.75 | 22.00 ± 5.62 | 0.66 | 0.85 |
| Stroop Test - Interference | 11.90 ± 28.77 | 2.90 ± 6.88 | -0.34 | 0.89 |
| TMT B-A | 68.42 ± 81.38 | 64.75 ± 41.85 | 0.84 | 0.85 |
| AES | 29.25 ± 7.24 | 32.00 ± 5.95 | 0.72 | 0.85 |
| MADRS | 2.92 ± 3.53 | 13.92 ± 27.85 | 1.82 | 0.36 |
| STAI-A State | 35.17 ± 21.31 | 45.75 ± 21.17 | 2.26 | 0.21 |
| STAI-B Trait | 40.83 ± 21.51 | 48.92 ± 18.76 | 1.97 | 0.33 |
AES Apathy Evaluation Scale, L-DOPA levodopa-equivalent daily dose, LPD patients with Parkinson’s disease exhibiting predominantly left-sided motor symptoms, MADRS Montgomery-Åsberg Depression Rating Scale, MDRS Mattis Dementia Rating Scale, RPD patients with Parkinson’s disease exhibiting predominantly right-sided motor symptoms, SD standard deviation, STAI State-Trait Anxiety Inventory, TMT Trail Making Test, UPDRS Unified Parkinson’s Disease Rating Scale
*p < 0.05
Statistical results of comparisons between the two subgroups of patients with cerebellar stroke (LCBL and RCBL) on motor, neuropsychological and psychiatric data
| LCBL (mean ± | RCBL (mean ± | Stat. value | ||
|---|---|---|---|---|
| SARA | 2.20 ± 2.76 | 1.70 ± 2.26 | -0.57 | 0.85 |
| MOCA (total score) | 24.82 ± 3.74 | 23.92 ± 2.90 | -0.55 | 0.85 |
| Categorical verbal fluency | 18.18 ± 7.52 | 17.31 ± 7.72 | 0.35 | 0.89 |
| Action (Verb) Fluency | 14.45 ± 4.32 | 13.08 ± 8.28 | 0.69 | 0.85 |
| FAB | 14.20 ± 2.48 | 15.50 ± 2.50 | 1.17 | 0.83 |
| AES | 5.70 ± 6.50 | 1.60 ± 3.06 | 1.17 | 0.83 |
| BDI-II | 11.82 ± 6.66 | 13.50 ± 6.81 | 0.61 | 0.85 |
| TAS-20 | 54.20 ± 17.66 | 53.11 ± 16.42 | 0.04 | 0.98 |
AES Apathy Evaluation Scale, BDI-II Beck Depression Inventory, FAB Frontal Assessment Battery, LCBL patients with left cerebellar stroke, MOCA Montreal Cognitive Assessment, RCBL patients with right cerebellar stroke, SARA Scale for the Assessment and Rating of Ataxia, SD standard deviation, TAS-20 Toronto Alexithymia Scale
Statistical results of clinical and healthy groups (LPD, RPD, LCBL, RCBL, and HC) comparisons on demographic and clinical data
| LPD (mean ± | RPD (mean ± | LCBL (mean ± | RCBL (mean ± | HC (mean ± | Stat. value | ||
|---|---|---|---|---|---|---|---|
| Age | 58.75 ± 7.56 | 54.58 ± 6.87 | 62.37 ± 10.15 | 61.38 ± 12.33 | 60.37 ± 8.91 | 1.29 | 0.86 |
| Education level | 12.08 ± 3.45 | 12.17 ± 3.07 | 12.64 ± 4.10 | 16.00 ± 4.67 | 13.58 ± 2.57 | 8.55 | 0.36 |
| Sex | 1.42 ± 0.51 | 1.42 ± 0.51 | 1.54 ± 0.52 | 1.38 ± 0.51 | 1.46 ± 0.51 | 0.73 | 0.97 |
| Handedness | 1.17 ± 0.39 | 1.00 ± 0.00 | 1.09 ± 0.30 | 1.08 ± 0.28 | 1.08 ± 0.28 | 2.17 | 0.89 |
| Disease duration / Time since stroke (days) | 4227.92 ± 1686.76 | 4197.50 ± 1439.11 | 1301.45 ± 1351.48 | 517.08 ± 430.34 | NA | 31.99 |
HC healthy controls, LCBL patients with left cerebellar stroke, LPD patients with Parkinson’s disease exhibiting predominantly left-sided motor symptoms, RCBL patients with right cerebellar stroke, RPD patients with Parkinson’s disease exhibiting predominantly right-sided motor symptoms, SD standard deviation
*p < 0.05
Significant contrasts between each group (LPD, RPD, LCBL, RCBL, HC) on each vocal emotion and each rating scale, revealed by the second level of analysis
| Emotion | Scale | Contrast direction | Stat. value | Bayes factor | |
|---|---|---|---|---|---|
| Anger | Fear | LCBL > HC | -2.27 | 0.05 | 5.38 |
| Surprise | RCBL > RPD | 2.32 | 0.04 | 9.16 | |
| Sadness | LPD > RPD | -4.71 | <0.001 | 7,372.80 | |
| RCBL > RPD | 3.53 | <0.001 | 5.62 | ||
| LCBL > RPD | 4.43 | <0.001 | 12.28 | ||
| HC > RPD | 3.53 | <0.001 | 3.54 | ||
| Happiness | Surprise | LPD > RPD | -2.37 | 0.03 | 110.77 |
| LPD > LCBL | -2.25 | 0.05 | 71.95 | ||
| Sadness | LPD > RPD | -2.52 | 0.02 | 25.59 | |
| HC > RPD | 2.89 | <0.01 | 20.54 | ||
| Neutral | Anger | LPD > RPD | -7.50 | <0.001 | 4,846.63 |
| LPD > LCBL | -2.56 | 0.02 | 35.38 | ||
| LPD > RCBL | -2.56 | 0.02 | 9.86 | ||
| LPD > HC | -5.32 | <0.001 | 208,811.68 | ||
| LCBL > RPD | 5.04 | <0.001 | 3.08 | ||
| RCBL > RPD | 5.24 | <0.001 | 3.95 | ||
| Happiness | RCBL > LCBL | 2.53 | 0.02 | 4.45 | |
| RCBL > HC | -2.28 | 0.04 | 20.61 | ||
| Fear | LPD > RPD | -3.14 | <0.01 | 247.86 | |
| LPD > HC | -3.16 | <0.01 | 5,316.21 | ||
| RCBL > HC | -2.67 | 0.01 | 3.29 | ||
| Sadness | LPD > RPD | -3.45 | <0.001 | 9,122.35 | |
| LCBL > RPD | 4.37 | <0.001 | 73.99 | ||
| Fear | Happiness | RCBL > LCBL | 4.64 | <0.001 | 5.91 |
| Surprise | RCBL > RPD | 3.23 | 0.003 | 55,663.05 | |
| Sadness | Anger | LPD > RPD | -2.88 | 0.008 | 27.27 |
| LPD > HC | -2.97 | 0.006 | 1,589.45 | ||
| Surprise | RCBL > RPD | 3.30 | 0.002 | 3.08 | |
| RCBL > HC | -3.43 | 0.001 | 20.43 |
HC healthy controls, LCBL patients with left cerebellar stroke, LPD patients with Parkinson’s disease exhibiting predominantly left-sided motor symptoms, RCBL patients with right cerebellar stroke, RPD patients with Parkinson’s disease exhibiting predominantly right-sided motor symptoms
Fig. 1a Mean ratings on the Sadness scale (left) and differential impact of disease duration / time since stroke (right) when the stimulus was anger for the HC (grey), RCBL (blue), LBCL (green), RPD (orange), and LPD (purple) groups. b Mean ratings on the Fear scale (left) and differential impact of disease duration / time since stroke (right) when the stimulus was neutral for the HC (grey), RCBL (blue), LBCL (green), RPD (orange), and LPD (purple) groups. c Mean ratings on the Happiness scale (left) and differential impact of disease duration / time since stroke (right) when the stimulus was fear for the HC (grey), RCBL (blue), LBCL (green), RPD (orange), and LPD (purple) groups. d Mean ratings on the Surprise scale (left) and differential impact of disease duration / time since stroke (right) when the stimulus was sadness for the HC (grey), RCBL (blue), LBCL (green), RPD (orange), and LPD (purple) groups. *p < 0.05